Aug 3, 2026 04:26PM
Aug 3, 2026 04:15PM
May 4, 2026 04:30PM
Feb 12, 2026 05:17PM
Feb 12, 2026 04:30PM
Nov 11, 2025 04:13AM
Nov 11, 2025 04:03AM Oppenheimer Reiterates Outperform Rating on CRISPR Therapeutics (CRSP)
Nov 10, 2025 03:25PM
Nov 10, 2025 08:12AM
Nov 10, 2025 08:00AM
Aug 7, 2025 07:18AM
Aug 5, 2025 06:02AM
Aug 4, 2025 04:51PM
Aug 4, 2025 04:15PM CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
May 6, 2025 05:31PM
May 6, 2025 04:01PM
Feb 17, 2025 04:34AM
Feb 11, 2025 04:28PM
Feb 11, 2025 04:01PM
Nov 5, 2024 09:01AM
Aug 5, 2024 04:04PM CRISPR Therapeutics (CRSP) Misses Q2 EPS by 6c
Aug 5, 2024 04:01PM
Jul 23, 2024 09:05AM
May 9, 2024 06:27AM
May 8, 2024 04:00PM
Feb 21, 2024 08:05AM
Feb 21, 2024 07:30AM
Feb 13, 2024 05:56AM CRISPR Therapeutics (CRSP) Announces EU Approval of CASGEVY
Feb 13, 2024 02:30AM
Jan 16, 2024 04:01PM
Jan 16, 2024 04:01PM
Dec 8, 2023 12:05PM
Nov 16, 2023 04:53AM
Nov 16, 2023 01:45AM
Nov 6, 2023 05:25PM CRISPR Therapeutics (CRSP) Tops Q3 EPS by 58c
Nov 6, 2023 04:15PM
Aug 7, 2023 04:42PM
Aug 7, 2023 04:01PM
May 8, 2023 04:48PM
May 8, 2023 04:01PM
Feb 21, 2023 05:01PM
Feb 21, 2023 04:01PM CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Nov 1, 2022 04:01PM
Aug 8, 2022 08:00AM
May 9, 2022 04:01PM
Feb 15, 2022 04:02PM
Feb 15, 2022 04:01PM
Nov 10, 2021 05:05PM
Nov 3, 2021 04:01PM CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
Jul 29, 2021 04:30PM

1,215,054 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All